Trial · NCT02833155
Entinostat in Chinese Postmenopausal Women Patients With Locally Recurrent or Metastatic Breast Cancer
NCT02833155, Phase 1, Completed, Taizhou EOC Pharma Co., Ltd.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Entinostat in Chinese Postmenopausal Women Patients With Locally Recurrent or Metastatic Breast Cancer. Trials, record NCT02833155. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02833155
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Entinostat in Chinese Postmenopausal Women Patients With Locally Recurrent or Metastatic Breast Cancer
- NCT number
- NCT02833155
- Status
- Completed
- Phases
- Phase 1
- Enrollment
- 19 participants, actual
- Lead sponsor
- Taizhou EOC Pharma Co., Ltd.
- Conditions
- Breast Cancer
- Interventions
- Entinostat, Exemestane
- First posted
- 2016-07-14
- Last updated
- 2019-05-07
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Adverse events, 12-lead ECG, blood pressure/pulse, temperature, laboratory parameters and physical examination. | Up to 28 days | |
| Secondary | Cmax,maximum plasma concentration | Pre-dose, Days 1,2,3,4,5,7,15 and 22 | |
| Secondary | tmax,time at which maximum plasma concentration was observed | Pre-dose, Days 1,2,3,4,5,7,15 and 22 | |
| Secondary | AUC 0-168h area under the plasma concentration-time curve from time zero to 168h | Pre-dose, Days 1,2,3,4,5 and 7 | |
| Secondary | AUC 0-inf,area under the plasma concentration-time curve from time zero to infinity | Pre-dose, Days 1,2,3,4,5,7,15 and 22 | |
| Secondary | T1/2, elimination half-life | Pre-dose, Days 1,2,3,4,5,7,15 and 22 | |
| Secondary | lambda z , apparent terminal phase elimination constant (λz) | Pre-dose, Days 1,2,3,4,5,7,15 and 22 | |
| Secondary | MRT，mean residence time | Pre-dose, Days 1,2,3,4,5,7,15 and 22 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 34196874 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02833155
GET https://conductscience.org/api/trials/v1/NCT02833155/registered